Non-animal supply
Fungal and recombinant-yeast production platforms.
MYKITO SCIENCESNON-ANIMAL CHITOSAN · ENGINEERED, NOT HARVESTED
Mykito Sciences grows pharmaceutical- and industrial-grade chitosan through fermentation and fungal cultivation—never crustaceans. Two platforms free one remarkable polymer from a fragile shellfish supply chain.
Discover why chitosanTHE MYKITO DIFFERENCE
Fungal and recombinant-yeast production platforms.
MW, DDA and functional performance shaped around the application.

SOURCE → SPECIFICATION → FORMAT
Mykito connects non-animal production, molecular engineering and application-ready material forms in one development platform.
Explore the technology
PURITY · CONSISTENCY · TESTING
Every Mykito batch is built around traceability, repeatable molecular specifications and application-relevant testing. Controlled non-animal production is the foundation; a pharmaceutical-minded quality culture turns that biology into a material customers can confidently evaluate.
Advanced laboratory equipment supporting material characterization and quality control.
Manufacturing infrastructure built for demanding food, medical, pharmaceutical and industrial programs.
Non-animal chitosan made without shrimp, crab or other crustacean inputs.
Mykito reports a substantial reduction versus the conventional industry route.
EXPLORE MYKITO
Understand the rare positive charge—and the two barriers that have constrained adoption.
↘02Explore Mykito’s source platforms and the engineering system that turns chitosan into a specification.
↘03See how Mykito converts chitosan into powders, films, fibers, hydrogels, sponges and finished formulations.
↘04Explore application pathways across pharma, medical devices, wound care, cosmetics, beauty, preservation and agriculture.
↘05Explore six application-led product platforms spanning wound care, preservation, hair care, agriculture and beverages.
↘